Funding for this research was provided by:
National Institute on Drug Abuse (UG1DA050065, UG1DA050070, UG1DA050069)
Indiana University (not applicable)
Received: 6 December 2021
Accepted: 24 May 2022
First Online: 4 August 2022
: All procedures described below were approved by the authors’ individual Institutional Review Boards (Chestnut Health Systems study #1148–1220; Indiana University #1910282231; University of Kentucky protocol #51656 2019). For IL data, a waiver of written consent was granted, and verbal informed consent was obtained from all participants.
: Not applicable.
: The authors have no competing interests to declare.